ENANTA PHARMACEUTICALS, INC Gain (Loss) on Disposition of Assets
ENANTA PHARMACEUTICALS, INC (ENTA) reported Gain (Loss) on Disposition of Assets of $0 for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-08-12
- ENANTA PHARMACEUTICALS, INC gain (loss) on disposition of assets for the quarter ending 2026-06-30 was $0.00.
- ENANTA PHARMACEUTICALS, INC gain (loss) on disposition of assets for the quarter ending 2026-03-31 was $0.00.
- ENANTA PHARMACEUTICALS, INC gain (loss) on disposition of assets for the quarter ending 2025-12-31 was $0.00.
- ENANTA PHARMACEUTICALS, INC gain (loss) on disposition of assets for the quarter ending 2025-09-30 was $0.00.
- ENANTA PHARMACEUTICALS, INC gain (loss) on disposition of assets for fiscal 2025 was -$6.00K.
- ENANTA PHARMACEUTICALS, INC gain (loss) on disposition of assets for fiscal 2024 was -$16.00K.
- ENANTA PHARMACEUTICALS, INC gain (loss) on disposition of assets for fiscal 2023 was -$150.00K.
- ENANTA PHARMACEUTICALS, INC gain (loss) on disposition of assets for fiscal 2022 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | $0.00 derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $0.00 10-Q · filed 2026-05-13 | $0.00 derived: sum of 3 quarters · filed 2026-05-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $0.00 10-Q · filed 2026-02-11 | $0.00 derived: sum of 2 quarters · filed 2026-02-11 | $0.00 derived: sum of 3 quarters · filed 2026-08-12 | $0.00 derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | $0.00 derived: sum of 2 quarters · filed 2026-08-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-12 | -$6.00K 10-K · filed 2025-11-19 |
| 2025-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-12 | -$6.00K 10-Q · filed 2026-08-12 | -$22.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | -$6.00K 10-Q · filed 2026-05-13 | -$22.00K derived: sum of 3 quarters · filed 2026-05-13 | -$22.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$6.00K 10-Q · filed 2026-02-11 | -$22.00K derived: sum of 2 quarters · filed 2026-02-11 | -$22.00K derived: sum of 3 quarters · filed 2026-02-11 | -$22.00K derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-09-30 | -$16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | -$16.00K derived: sum of 2 quarters · filed 2025-11-19 | -$16.00K derived: sum of 3 quarters · filed 2025-11-19 | -$16.00K 10-K · filed 2025-11-19 |
| 2024-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-13 | $0.00 derived: sum of 2 quarters · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | -$143.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | $0.00 10-Q · filed 2025-05-14 | -$143.00K derived: sum of 3 quarters · filed 2025-11-19 | -$143.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2023-12-31 | $0.00 10-Q · filed 2025-02-12 | -$143.00K derived: sum of 2 quarters · filed 2025-11-19 | -$143.00K derived: sum of 3 quarters · filed 2025-11-19 | |
| 2023-09-30 | -$143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | -$143.00K derived: sum of 2 quarters · filed 2025-11-19 | -$150.00K 10-K · filed 2025-11-19 | |
| 2023-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-07 | -$7.00K 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | -$7.00K 10-Q · filed 2024-05-08 | |||
| 2022-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | $0.00 derived: sum of 2 quarters · filed 2024-11-27 | $0.00 10-K · filed 2024-11-27 | |
| 2022-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | |||
| 2021-09-30 | $0.00 10-K · filed 2023-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |